APG Asset Management N.V. Purchases New Position in PerkinElmer, Inc. (PKI)
APG Asset Management N.V. purchased a new position in shares of PerkinElmer, Inc. (NYSE:PKI) in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 32,000 shares of the medical research company’s stock, valued at approximately $2,207,000.
Several other hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. grew its stake in shares of PerkinElmer by 2.6% during the 2nd quarter. Vanguard Group Inc. now owns 10,886,642 shares of the medical research company’s stock worth $741,816,000 after acquiring an additional 273,975 shares during the period. Janus Henderson Group PLC bought a new position in shares of PerkinElmer during the 2nd quarter worth $436,483,000. BlackRock Inc. grew its stake in shares of PerkinElmer by 2.4% during the 2nd quarter. BlackRock Inc. now owns 5,929,277 shares of the medical research company’s stock worth $404,022,000 after acquiring an additional 141,650 shares during the period. Pictet Asset Management Ltd. grew its stake in shares of PerkinElmer by 2.1% during the 2nd quarter. Pictet Asset Management Ltd. now owns 3,433,659 shares of the medical research company’s stock worth $216,526,000 after acquiring an additional 71,540 shares during the period. Finally, Dimensional Fund Advisors LP grew its stake in shares of PerkinElmer by 15.4% during the 1st quarter. Dimensional Fund Advisors LP now owns 891,832 shares of the medical research company’s stock worth $51,778,000 after acquiring an additional 118,995 shares during the period. Institutional investors own 91.38% of the company’s stock.
PerkinElmer, Inc. (NYSE:PKI) opened at $71.13 on Wednesday. PerkinElmer, Inc. has a 12 month low of $45.35 and a 12 month high of $73.05. The company has a quick ratio of 2.09, a current ratio of 2.59 and a debt-to-equity ratio of 0.44. The company has a market capitalization of $7,775.64, a PE ratio of 25.38, a price-to-earnings-growth ratio of 2.02 and a beta of 0.77.
The business also recently announced a quarterly dividend, which will be paid on Friday, February 9th. Shareholders of record on Friday, January 19th will be paid a $0.07 dividend. The ex-dividend date is Thursday, January 18th. This represents a $0.28 annualized dividend and a yield of 0.39%. PerkinElmer’s dividend payout ratio is currently 7.78%.
Several research firms have recently weighed in on PKI. Morgan Stanley increased their price target on PerkinElmer from $77.00 to $78.00 and gave the stock an “overweight” rating in a research note on Friday, November 3rd. Citigroup Inc. reiterated a “buy” rating and set a $80.00 price target (up previously from $74.00) on shares of PerkinElmer in a research note on Tuesday, September 26th. Goldman Sachs Group, Inc. (The) reiterated a “neutral” rating and set a $67.00 price target on shares of PerkinElmer in a research note on Tuesday, September 26th. Zacks Investment Research upgraded PerkinElmer from a “hold” rating to a “buy” rating and set a $74.00 price target for the company in a research note on Tuesday, August 1st. Finally, Wells Fargo & Company began coverage on PerkinElmer in a research note on Thursday, July 13th. They set a “market perform” rating and a $72.00 price target for the company. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and six have given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $68.64.
PerkinElmer Company Profile
PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets.
Receive News & Ratings for PerkinElmer Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.